CDCA5 and breast cancer: In the same vein as to the mRNA analysis, when the BC cohort was stratified based on LVI, the high expression of the CDCA5 protein was associated with shorter BCSS in the LVI-positive subgroup (p = 0.008, HR 1.85, 95% CI; 1.17–2.92; Figure 2E).